Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela E Aust

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Oncoimmunology|January 9, 2018
Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancerArmin Jarosch, Ulrich Sommer, Andreas Bogner, et al.
BMC Surgery|May 10, 2017
Clinical impact of duodenal pancreatic heterotopia - Is there a need for surgical treatment?Alexander Betzler, Soeren T Mees, Josefine Pump, et al.
Scientific Reports|September 5, 2019
The pathohistological subtype strongly predicts survival in patients with ampullary carcinomaCarolin Zimmermann, Steffen Wolk, Daniela E Aust, et al.
The American Journal of Surgical Pathology|August 26, 2006
Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapyChristiane Jakob, Torsten Liersch, Wolfdietrich Meyer, et al.
Cancer Letters|August 30, 2008
Thymidylate synthase genotypes and tumour regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiationJan Stoehlmacher, Eray Goekkurt, Ulrike Mogck, et al.
Oncotarget|December 31, 2015
Simultaneous gene silencing of KRAS and anti-apoptotic genes as a multitarget therapyKristin Werner, Franziska Lademann, May-Linn Thepkaysone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2023
TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic CancerMax Heiduk, Anna Klimova, Charlotte Reiche, et al.
Langenbeck'S Archives of Surgery|March 13, 2021
Impact of resection margin status on survival in advanced N stage pancreatic cancer - a multi-institutional analysisChristian Teske, Richard Stimpel, Marius Distler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapyTorsten Liersch, Claus Langer, B Michael Ghadimi, et al.
European Journal of Human Genetics : EJHG|January 19, 2006
Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumorJens Plaschke, Michael Linnebacher, Matthias Kloor, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Oncoimmunology|January 9, 2018
Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancerArmin Jarosch, Ulrich Sommer, Andreas Bogner, et al.
BMC Surgery|May 10, 2017
Clinical impact of duodenal pancreatic heterotopia - Is there a need for surgical treatment?Alexander Betzler, Soeren T Mees, Josefine Pump, et al.
Scientific Reports|September 5, 2019
The pathohistological subtype strongly predicts survival in patients with ampullary carcinomaCarolin Zimmermann, Steffen Wolk, Daniela E Aust, et al.
The American Journal of Surgical Pathology|August 26, 2006
Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapyChristiane Jakob, Torsten Liersch, Wolfdietrich Meyer, et al.
Cancer Letters|August 30, 2008
Thymidylate synthase genotypes and tumour regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiationJan Stoehlmacher, Eray Goekkurt, Ulrike Mogck, et al.
Oncotarget|December 31, 2015
Simultaneous gene silencing of KRAS and anti-apoptotic genes as a multitarget therapyKristin Werner, Franziska Lademann, May-Linn Thepkaysone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2023
TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic CancerMax Heiduk, Anna Klimova, Charlotte Reiche, et al.
Langenbeck'S Archives of Surgery|March 13, 2021
Impact of resection margin status on survival in advanced N stage pancreatic cancer - a multi-institutional analysisChristian Teske, Richard Stimpel, Marius Distler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapyTorsten Liersch, Claus Langer, B Michael Ghadimi, et al.
European Journal of Human Genetics : EJHG|January 19, 2006
Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumorJens Plaschke, Michael Linnebacher, Matthias Kloor, et al.
Pageof 8